Roche Tamiflu's Effectiveness Unproven Due to Hidden Data, Researchers Say
Roche Holding AG (ROG)'s Tamiflu antiviral treatment may not be as safe and effective as the Swiss drugmaker says, according to independent researchers who asked the company to publish data withheld from public review.
While Tamiflu helps flu sufferers feel better an average of 21 hours more quickly after initial symptoms, it didn't reduce the number of people who went on to be hospitalized, researchers at the non-profit Cochrane Collaboration said today in a report. Though stockpiled to prevent the spread of flu, the drug hasn't been proven effective for that purpose, the British Medical Journal said in an article published with the Cochrane report ....
No comments:
Post a Comment